Patent ID: 8541363
Filing Date: 2013-09-24
Classification: A01N,A61K,A61P,C07K

Abstract:
1. A compound selected from compounds of the following formula, and pharmaceutically acceptable salts thereof: wherein: —R —R —R —R —R —R —R —R —R —R —R —R —R -L —R —R —R —R —R —R —R —R —R —R —R —R —R or —R —R —R —R each —R each —R each —R each —R each —R each —R each -L —R —R —R —R —R or —NR —R —R wherein each —R —F, —Cl, —Br, —I, phenyl, —CF wherein each —R wherein each phenyl is optionally substituted with one or more groups selected from: —F, —Cl, —Br, —I, —R and wherein each —R —F, —Cl, —Br, —I, —R wherein each —R wherein each phenyl is optionally substituted with one or more groups selected from: —F, —Cl, —Br, —I, —R and wherein each —R —F, —Cl, —Br, —I, —R —CH═CH —CF —CN, —NO —OH, —OR -L —O-L —NH pyrrolidino, piperidino, morpholino, piperizino, N—(C -L -L -L -L —O-L —O-L —O-L —O-L —NHC(═O)R —C(═O)R —C(═O)OH, —C(═O)OR —C(═O)NH —C(═O)-pyrrolidino, —C(═O)-piperidino, —C(═O)-morpholino, —C(═O)-piperizino, —C(═O)—{N—(C —NHC(═O)NH —NHC(═O)-pyrrolidino, —NHC(═O)-piperidino, —NHC(═O)-morpholino, —NHC(═O)-piperizino, —NHC(═O)—{N—(C —S(═O) —S(═O) ═O; wherein each -L wherein each —R wherein each phenyl is optionally substituted with one or more groups selected from: —F, —Cl, —Br, —I, —R wherein each C wherein each —R and additionally, two adjacent groups —R and additionally, two adjacent groups —R